IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+8.94%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$241M
AUM Growth
+$241M
Cap. Flow
+$12.8M
Cap. Flow %
5.3%
Top 10 Hldgs %
40.16%
Holding
106
New
29
Increased
9
Reduced
21
Closed
6

Top Buys

1
MRK icon
Merck
MRK
$10.6M
2
BBIO icon
BridgeBio Pharma
BBIO
$9.86M
3
INSM icon
Insmed
INSM
$8.27M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$7.32M
5
APLS icon
Apellis Pharmaceuticals
APLS
$6.6M

Top Sells

1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
$17.5M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$10.2M
3
BHVN icon
Biohaven
BHVN
$5.94M
4
CLDX icon
Celldex Therapeutics
CLDX
$5.81M
5
ETNB icon
89bio
ETNB
$5.78M

Sector Composition

1 Healthcare 97.84%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BIIB icon
76
Biogen
BIIB
$20.8B
$267K 0.06%
962
– –
PHXM
77
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$252K 0.06%
24,843
+24,541
+8,126% +$249K
CNTB
78
Connect Biopharma
CNTB
$111M
$219K 0.05%
219,501
– –
SYBX icon
79
Synlogic
SYBX
$17.4M
$194K 0.04%
20,450
– –
ARKK icon
80
ARK Innovation ETF
ARKK
$7.43B
$182K 0.04%
4,519
– –
RLMD icon
81
Relmada Therapeutics
RLMD
$48.8M
$148K 0.03%
65,491
– –
BLCM
82
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$148K 0.03%
448,101
– –
SPPI
83
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$133K 0.03%
176,980
– –
GNFT
84
Genfit
GNFT
$198M
$132K 0.03%
+32,786
New +$132K
STSA
85
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$95K 0.02%
136,059
– –
FNCH
86
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$93.4K 0.02%
7,918
– –
RCKTW icon
87
Rocket Pharmaceuticals, Inc. Warrant
RCKTW
$4.17M
$60K 0.01%
+367,112
New +$60K
MDGL icon
88
Madrigal Pharmaceuticals
MDGL
$9.7B
$18.2K ﹤0.01%
75
– –
CYCC icon
89
Cyclacel Pharmaceuticals
CYCC
$17.2M
$11K ﹤0.01%
+76
New +$11K
GOSS icon
90
Gossamer Bio
GOSS
$587M
$7.69K ﹤0.01%
6,100
– –
ARVN icon
91
Arvinas
ARVN
$580M
– –
0
– –
AXSM icon
92
Axsome Therapeutics
AXSM
$6.09B
– –
0
– –
CABA icon
93
Cabaletta Bio
CABA
$144M
– –
-30,286
Closed -$280K
DSGN icon
94
Design Therapeutics
DSGN
$339M
– –
-11,568
Closed -$119K
ETNB icon
95
89bio
ETNB
$1.37B
– –
-454,000
Closed -$5.78M
GERN icon
96
Geron
GERN
$893M
– –
0
– –
KRYS icon
97
Krystal Biotech
KRYS
$4.35B
– –
0
– –
PRAX icon
98
Praxis Precision Medicines
PRAX
$980M
– –
-10,000
Closed -$357K
PTCT icon
99
PTC Therapeutics
PTCT
$4.41B
– –
0
– –
PTGX icon
100
Protagonist Therapeutics
PTGX
$3.62B
– –
0
– –
1 2 3
4
5